drugset / Trial / NCT05074602

A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Candidiasis

NCT05074602

Phase 3 Unknown 196 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the Efficacy and Safety of SHR8008 capsule In Subjects With Recurrent Vulvovaginal Candidiasis

Timeline

Start
2021-09-14
Primary completion
2023-09-30
Completion
2023-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluconazole Small molecule Oral
Subject SHR8008 Unknown Oral